Cart
sales@molnova.com
Copper histidine
CAS No. 77280-83-2
Copper histidine( —— )
Catalog No. M36126 CAS No. 77280-83-2
Copper histidine inhibited Ctr1-mediated cellular uptake of oxaliplatin in vitro without altering oxaliplatin accumulation of platinum or neurotoxicity in DRG tissues in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 168 | In Stock |
|
| 10MG | 247 | In Stock |
|
| 25MG | 481 | In Stock |
|
| 50MG | 642 | In Stock |
|
| 100MG | 913 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1832 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCopper histidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCopper histidine inhibited Ctr1-mediated cellular uptake of oxaliplatin in vitro without altering oxaliplatin accumulation of platinum or neurotoxicity in DRG tissues in vivo.
-
DescriptionCopper histidine inhibited Ctr1-mediated cellular uptake of oxaliplatin in vitro without altering oxaliplatin accumulation of platinum or neurotoxicity in DRG tissues in vivo. Copper histidine is administered orally for the treatment of Menkes disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number77280-83-2
-
Formula Weight217.69
-
Molecular FormulaC6H8CuN3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1[O-][Cu+2]2[N]3(C(C[C@@]1([NH2]2)[H])=CN=C3)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Rovazolac
Rovazolac (ALX-101) is a liver x receptor (LXR) modulator used in the study of immune system disorders and atopic dermatitis.
-
CD73-IN-4
CD73-IN-4 is a potent and selective methylenephosphonic acid?CD73?inhibitor.
-
PKUMDL-WQ-2101
PKUMDL-WQ-2101 is a selective allosteric inhibitor of phosphoglycerate dehydrogenase (PHGDH) with anti-tumor activity, it binds to site I.
